PDCD1 and neoplasm: To further characterize the anti-tumor effect of our HA PD-1 Ig we compared it to a function blocking anti-PD-L1 monoclonal antibody (mPD-L1 Ab clone 10F.9G2), in combination with radiation therapy using the same 3LL lung tumor model.